epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/naproxen
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Back & Muscle Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic regulatory T cell immunotherapy with HSPC and T cells
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambelvist
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Ixchiq

chikungunya vaccine, live

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  INJ

Withdrawn from US Market

[January 2026]
Info: voluntarily withdrawn following FDA approval suspension due to severe neurologic and cardiac adverse events

Peds Dosing .

Dosage forms:  --

Withdrawn from US Market

[January 2026]
Info: voluntarily withdrawn following FDA approval suspension due to severe neurologic and cardiac adverse events

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@5559a406
  • hypersensitivity to drug or ingredient
  • immunocompromised patients
  • caution: patients 65 yo and older with chronic conditions
  • caution: illness, acute moderate-severe

Drug Interactions .

Overview

chikungunya vaccine, live

live vaccine

Interaction Characteristics:
  • live vaccine
Other Info
  • Withdrawn from US Market

Contraindicated

  • abatacept
  • Ixchiq (chikungunya vaccine, live)
    +
    abatacept
    1 interaction

    Contraindicated

    chikungunya vaccine, live + abatacept

    contraindicated; vaccinate at least 4wk before or 3mo after abatacept tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • abemaciclib
  • Ixchiq (chikungunya vaccine, live)
    +
    abemaciclib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + abemaciclib

    contraindicated; vaccinate at least 4wk before or 3mo after abemaciclib use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • abrocitinib
  • Ixchiq (chikungunya vaccine, live)
    +
    abrocitinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + abrocitinib

    contraindicated; vaccinate at least 4wk before or 3mo after abrocitinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • acalabrutinib
  • Ixchiq (chikungunya vaccine, live)
    +
    acalabrutinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + acalabrutinib

    contraindicated; vaccinate at least 4wk before or 3mo after acalabrutinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • adalimumab
  • Ixchiq (chikungunya vaccine, live)
    +
    adalimumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + adalimumab

    contraindicated; vaccinate at least 4wk before or 3mo after adalimumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • afamitresgene autoleucel
  • Ixchiq (chikungunya vaccine, live)
    +
    afamitresgene autoleucel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + afamitresgene autoleucel

    contraindicated; vaccinate at least 4wk before or 3mo after afamitresgene autoleucel use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • aldesleukin
  • Ixchiq (chikungunya vaccine, live)
    +
    aldesleukin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + aldesleukin

    contraindicated; vaccinate at least 4wk before or 3mo after aldesleukin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • alemtuzumab
  • Ixchiq (chikungunya vaccine, live)
    +
    alemtuzumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + alemtuzumab

    contraindicated; vaccinate at least 6wk before or 6mo after alemtuzumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • amivantamab
  • Ixchiq (chikungunya vaccine, live)
    +
    amivantamab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + amivantamab

    contraindicated; vaccinate at least 4wk before or 3mo after amivantamab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • anakinra
  • Ixchiq (chikungunya vaccine, live)
    +
    anakinra
    1 interaction

    Contraindicated

    chikungunya vaccine, live + anakinra

    contraindicated; vaccinate at least 4wk before or 3mo after anakinra tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • anifrolumab
  • Ixchiq (chikungunya vaccine, live)
    +
    anifrolumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + anifrolumab

    contraindicated; vaccinate at least 4wk before or 3mo after anifrolumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • anti-thymocyte globulin
  • Ixchiq (chikungunya vaccine, live)
    +
    anti-thymocyte globulin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + anti-thymocyte globulin

    contraindicated; vaccinate at least 4wk before or 6mo after anti-thymocyte globulin use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • asciminib
  • Ixchiq (chikungunya vaccine, live)
    +
    asciminib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + asciminib

    contraindicated; vaccinate at least 4wk before or 3mo after asciminib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • atacicept
  • Ixchiq (chikungunya vaccine, live)
    +
    atacicept
    1 interaction

    Contraindicated

    chikungunya vaccine, live + atacicept

    contraindicated; vaccinate at least 4wk before or 6mo after atacicept use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • atezolizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    atezolizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + atezolizumab

    contraindicated; vaccinate at least 4wk before or 3-6mo after atezolizumab tx or immunocompetence restored: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • atidarsagene autotemcel
  • Ixchiq (chikungunya vaccine, live)
    +
    atidarsagene autotemcel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + atidarsagene autotemcel

    contraindicated; vaccinate at least 6wk before myeloablative conditioning or after hematologic recovery: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • avelumab
  • Ixchiq (chikungunya vaccine, live)
    +
    avelumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + avelumab

    contraindicated; vaccinate at least 4wk before or 3mo after avelumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • axicabtagene ciloleucel
  • Ixchiq (chikungunya vaccine, live)
    +
    axicabtagene ciloleucel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + axicabtagene ciloleucel

    contraindicated; vaccinate at least 6wk before lymphodepleting chemotherapy or after immune recovery: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • azacitidine
  • Ixchiq (chikungunya vaccine, live)
    +
    azacitidine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + azacitidine

    contraindicated; vaccinate at least 4wk before or 3mo after azacitidine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • azathioprine
  • Ixchiq (chikungunya vaccine, live)
    +
    azathioprine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + azathioprine

    contraindicated; vaccinate at least 4wk before or 3mo after azathioprine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • baricitinib
  • Ixchiq (chikungunya vaccine, live)
    +
    baricitinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + baricitinib

    contraindicated; vaccinate at least 4wk before or 3mo after baricitinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • basiliximab
  • Ixchiq (chikungunya vaccine, live)
    +
    basiliximab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + basiliximab

    contraindicated; vaccinate at least 4wk before or 3mo after basiliximab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • belantamab mafodotin
  • Ixchiq (chikungunya vaccine, live)
    +
    belantamab mafodotin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + belantamab mafodotin

    contraindicated; vaccinate at least 4wk before or 6mo after belantamab mafodotin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • belatacept
  • Ixchiq (chikungunya vaccine, live)
    +
    belatacept
    1 interaction

    Contraindicated

    chikungunya vaccine, live + belatacept

    contraindicated; vaccinate at least 4wk before or 3mo after belatacept tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • belimumab
  • Ixchiq (chikungunya vaccine, live)
    +
    belimumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + belimumab

    contraindicated; vaccinate at least 30 days before or 6mo after belimumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • belinostat
  • Ixchiq (chikungunya vaccine, live)
    +
    belinostat
    1 interaction

    Contraindicated

    chikungunya vaccine, live + belinostat

    contraindicated; vaccinate at least 4wk before or 3mo after belinostat tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • bendamustine
  • Ixchiq (chikungunya vaccine, live)
    +
    bendamustine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + bendamustine

    contraindicated; vaccinate at least 4wk before or 3mo after bendamustine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • betamethasone
  • Ixchiq (chikungunya vaccine, live)
    +
    betamethasone
    1 interaction

    Contraindicated

    chikungunya vaccine, live + betamethasone

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • bimekizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    bimekizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + bimekizumab

    contraindicated; vaccinate at least 4wk before or 3mo after bimekizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • blinatumomab
  • Ixchiq (chikungunya vaccine, live)
    +
    blinatumomab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + blinatumomab

    contraindicated; vaccinate at least 4wk before or 6mo after blinatumomab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • bortezomib
  • Ixchiq (chikungunya vaccine, live)
    +
    bortezomib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + bortezomib

    contraindicated; vaccinate at least 4wk before or 3mo after bortezomib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • brensocatib
  • Ixchiq (chikungunya vaccine, live)
    +
    brensocatib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + brensocatib

    contraindicated; vaccinate at least 4wk before or 3mo after brensocatib: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • brentuximab vedotin
  • Ixchiq (chikungunya vaccine, live)
    +
    brentuximab vedotin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + brentuximab vedotin

    contraindicated; vaccinate at least 4wk before or 6mo after brentuximab vedotin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • brepocitinib
  • Ixchiq (chikungunya vaccine, live)
    +
    brepocitinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + brepocitinib

    contraindicated; vaccinate at least 4wk before or 3mo after brepocitinib use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • brexucabtagene autoleucel
  • Ixchiq (chikungunya vaccine, live)
    +
    brexucabtagene autoleucel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + brexucabtagene autoleucel

    contraindicated; vaccinate at least 6wk before lymphodepleting chemotherapy or after immune recovery: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • brodalumab
  • Ixchiq (chikungunya vaccine, live)
    +
    brodalumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + brodalumab

    contraindicated; vaccinate at least 4wk before or 3mo after brodalumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • budesonide
  • Ixchiq (chikungunya vaccine, live)
    +
    budesonide
    1 interaction

    Contraindicated

    chikungunya vaccine, live + budesonide

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • busulfan
  • Ixchiq (chikungunya vaccine, live)
    +
    busulfan
    1 interaction

    Contraindicated

    chikungunya vaccine, live + busulfan

    contraindicated; vaccinate at least 4wk before or 3mo after busulfan use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • cabazitaxel
  • Ixchiq (chikungunya vaccine, live)
    +
    cabazitaxel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + cabazitaxel

    contraindicated; vaccinate at least 4wk before or 3mo after cabazitaxel tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • canakinumab
  • Ixchiq (chikungunya vaccine, live)
    +
    canakinumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + canakinumab

    contraindicated; vaccinate at least 4wk before or 3mo after canakinumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • capecitabine
  • Ixchiq (chikungunya vaccine, live)
    +
    capecitabine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + capecitabine

    contraindicated; vaccinate at least 4wk before or 3mo after capecitabine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • carboplatin
  • Ixchiq (chikungunya vaccine, live)
    +
    carboplatin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + carboplatin

    contraindicated; vaccinate at least 4wk before or 3mo after carboplatin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • carfilzomib
  • Ixchiq (chikungunya vaccine, live)
    +
    carfilzomib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + carfilzomib

    contraindicated; vaccinate at least 4wk before or 3mo after carfilzomib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • carmustine
  • Ixchiq (chikungunya vaccine, live)
    +
    carmustine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + carmustine

    contraindicated; vaccinate at least 4wk before or 3mo after carmustine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • cemiplimab
  • Ixchiq (chikungunya vaccine, live)
    +
    cemiplimab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + cemiplimab

    contraindicated; vaccinate at least 4wk before or 3-6mo after cemiplimab use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • certolizumab pegol
  • Ixchiq (chikungunya vaccine, live)
    +
    certolizumab pegol
    1 interaction

    Contraindicated

    chikungunya vaccine, live + certolizumab pegol

    contraindicated; vaccinate at least 4wk before or 3mo after certolizumab pegol tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • chlorambucil
  • Ixchiq (chikungunya vaccine, live)
    +
    chlorambucil
    1 interaction

    Contraindicated

    chikungunya vaccine, live + chlorambucil

    contraindicated; vaccinate at least 4wk before or 3mo after chlorambucil tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ciltacabtagene autoleucel
  • Ixchiq (chikungunya vaccine, live)
    +
    ciltacabtagene autoleucel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ciltacabtagene autoleucel

    contraindicated; vaccinate at least 6wk before lymphodepleting chemotherapy or after immune recovery: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • cisplatin
  • Ixchiq (chikungunya vaccine, live)
    +
    cisplatin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + cisplatin

    contraindicated; vaccinate at least 4wk before or 3mo after cisplatin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • cladribine injection
  • Ixchiq (chikungunya vaccine, live)
    +
    cladribine injection
    1 interaction

    Contraindicated

    chikungunya vaccine, live + cladribine injection

    contraindicated; vaccinate at least 4wk before or 3mo after cladribine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • cladribine oral
  • Ixchiq (chikungunya vaccine, live)
    +
    cladribine oral
    1 interaction

    Contraindicated

    chikungunya vaccine, live + cladribine oral

    contraindicated; vaccinate at least 4wk before or 3mo after cladribine use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • clofarabine
  • Ixchiq (chikungunya vaccine, live)
    +
    clofarabine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + clofarabine

    contraindicated; vaccinate at least 4wk before or 3mo after clofarabine use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • copanlisib
  • Ixchiq (chikungunya vaccine, live)
    +
    copanlisib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + copanlisib

    contraindicated; vaccinate at least 4wk before or 3mo after copanlisib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • corticotropin
  • Ixchiq (chikungunya vaccine, live)
    +
    corticotropin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + corticotropin

    contraindicated; vaccinate at least 4wk before or 3mo after corticotropin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • cortisone
  • Ixchiq (chikungunya vaccine, live)
    +
    cortisone
    1 interaction

    Contraindicated

    chikungunya vaccine, live + cortisone

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • cosibelimab
  • Ixchiq (chikungunya vaccine, live)
    +
    cosibelimab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + cosibelimab

    contraindicated; vaccinate at least 4wk before or 3mo after cosibelimab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • cyclophosphamide
  • Ixchiq (chikungunya vaccine, live)
    +
    cyclophosphamide
    1 interaction

    Contraindicated

    chikungunya vaccine, live + cyclophosphamide

    contraindicated; vaccinate at least 4wk before or 3mo after cyclophosphamide tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • cyclosporine
  • Ixchiq (chikungunya vaccine, live)
    +
    cyclosporine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + cyclosporine

    contraindicated; vaccinate at least 4wk before or 3mo after cyclosporine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • cytarabine
  • Ixchiq (chikungunya vaccine, live)
    +
    cytarabine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + cytarabine

    contraindicated; vaccinate at least 4wk before or 3mo after cytarabine use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • dactinomycin
  • Ixchiq (chikungunya vaccine, live)
    +
    dactinomycin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + dactinomycin

    contraindicated; vaccinate at least 4wk before or 3mo after dactinomycin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • daratumumab
  • Ixchiq (chikungunya vaccine, live)
    +
    daratumumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + daratumumab

    contraindicated; vaccinate at least 4wk before or 6mo after daratumumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • dasatinib
  • Ixchiq (chikungunya vaccine, live)
    +
    dasatinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + dasatinib

    contraindicated; vaccinate at least 4wk before or 3mo after dasatinib use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • daunorubicin
  • Ixchiq (chikungunya vaccine, live)
    +
    daunorubicin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + daunorubicin

    contraindicated; vaccinate at least 4wk before or 3mo after daunorubicin use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • decitabine
  • Ixchiq (chikungunya vaccine, live)
    +
    decitabine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + decitabine

    contraindicated; vaccinate at least 4wk before or 3mo after decitabine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • deflazacort
  • Ixchiq (chikungunya vaccine, live)
    +
    deflazacort
    1 interaction

    Contraindicated

    chikungunya vaccine, live + deflazacort

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • delgocitinib topical
  • Ixchiq (chikungunya vaccine, live)
    +
    delgocitinib topical
    1 interaction

    Contraindicated

    chikungunya vaccine, live + delgocitinib topical

    contraindicated; vaccinate at least 4wk before or 3mo after delgocitinib topical tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • deucravacitinib
  • Ixchiq (chikungunya vaccine, live)
    +
    deucravacitinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + deucravacitinib

    contraindicated; vaccinate at least 4wk before or 3mo after deucravacitinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • deuruxolitinib
  • Ixchiq (chikungunya vaccine, live)
    +
    deuruxolitinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + deuruxolitinib

    contraindicated; vaccinate at least 4wk before or 3mo after deuruxolitinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • dexamethasone
  • Ixchiq (chikungunya vaccine, live)
    +
    dexamethasone
    1 interaction

    Contraindicated

    chikungunya vaccine, live + dexamethasone

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • dimethyl fumarate
  • Ixchiq (chikungunya vaccine, live)
    +
    dimethyl fumarate
    1 interaction

    Contraindicated

    chikungunya vaccine, live + dimethyl fumarate

    contraindicated; vaccinate at least 4wk before or 3mo after dimethyl fumarate tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • dinutuximab
  • Ixchiq (chikungunya vaccine, live)
    +
    dinutuximab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + dinutuximab

    contraindicated; vaccinate at least 4wk before or 3mo after dinutuximab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • diroximel fumarate
  • Ixchiq (chikungunya vaccine, live)
    +
    diroximel fumarate
    1 interaction

    Contraindicated

    chikungunya vaccine, live + diroximel fumarate

    contraindicated; vaccinate at least 4wk before or 3mo after diroximel fumarate tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • docetaxel
  • Ixchiq (chikungunya vaccine, live)
    +
    docetaxel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + docetaxel

    contraindicated; vaccinate at least 4wk before or 3mo after docetaxel tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • dostarlimab
  • Ixchiq (chikungunya vaccine, live)
    +
    dostarlimab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + dostarlimab

    contraindicated; vaccinate at least 4wk before or 3-6mo after dostarlimab tx or immunocompetence restored: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • doxorubicin
  • Ixchiq (chikungunya vaccine, live)
    +
    doxorubicin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + doxorubicin

    contraindicated; vaccinate at least 4wk before or 3mo after doxorubicin use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • dupilumab
  • Ixchiq (chikungunya vaccine, live)
    +
    dupilumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + dupilumab

    contraindicated; vaccinate at least 4wk before or 3mo after dupilumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • durvalumab
  • Ixchiq (chikungunya vaccine, live)
    +
    durvalumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + durvalumab

    contraindicated; vaccinate at least 4wk before or 3mo after durvalumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • duvelisib
  • Ixchiq (chikungunya vaccine, live)
    +
    duvelisib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + duvelisib

    contraindicated; vaccinate at least 4wk before or 3mo after duvelisib use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • efgartigimod alfa
  • Ixchiq (chikungunya vaccine, live)
    +
    efgartigimod alfa
    1 interaction

    Contraindicated

    chikungunya vaccine, live + efgartigimod alfa

    contraindicated; vaccinate at least 4wk before or 3mo after efgartigimod alfa tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • elivaldogene autotemcel
  • Ixchiq (chikungunya vaccine, live)
    +
    elivaldogene autotemcel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + elivaldogene autotemcel

    contraindicated; vaccinate at least 6wk before myeloablative conditioning or after hematologic recovery: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • elotuzumab
  • Ixchiq (chikungunya vaccine, live)
    +
    elotuzumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + elotuzumab

    contraindicated; vaccinate at least 4wk before or 3mo after elotuzumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • elranatamab
  • Ixchiq (chikungunya vaccine, live)
    +
    elranatamab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + elranatamab

    contraindicated; vaccinate at least 4wk before or 6mo after elranatamab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • emapalumab
  • Ixchiq (chikungunya vaccine, live)
    +
    emapalumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + emapalumab

    contraindicated; vaccinate at least 4wk before or 3mo after emapalumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • epcoritamab
  • Ixchiq (chikungunya vaccine, live)
    +
    epcoritamab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + epcoritamab

    contraindicated; vaccinate at least 4wk before or 6mo after epcoritamab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • epirubicin
  • Ixchiq (chikungunya vaccine, live)
    +
    epirubicin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + epirubicin

    contraindicated; vaccinate at least 4wk before or 3mo after epirubicin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • erdafitinib
  • Ixchiq (chikungunya vaccine, live)
    +
    erdafitinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + erdafitinib

    contraindicated; vaccinate at least 4wk before or 3mo after erdafitinib use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • eribulin
  • Ixchiq (chikungunya vaccine, live)
    +
    eribulin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + eribulin

    contraindicated; vaccinate at least 4wk before or 3mo after eribulin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • etanercept
  • Ixchiq (chikungunya vaccine, live)
    +
    etanercept
    1 interaction

    Contraindicated

    chikungunya vaccine, live + etanercept

    contraindicated; vaccinate at least 4wk before or 3mo after etanercept use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • etoposide
  • Ixchiq (chikungunya vaccine, live)
    +
    etoposide
    1 interaction

    Contraindicated

    chikungunya vaccine, live + etoposide

    contraindicated; vaccinate at least 4wk before or 3mo after etoposide use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • etrasimod
  • Ixchiq (chikungunya vaccine, live)
    +
    etrasimod
    1 interaction

    Contraindicated

    chikungunya vaccine, live + etrasimod

    contraindicated; vaccinate at least 1mo before or 3mo after etrasimod tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • etuvetidigene autotemcel
  • Ixchiq (chikungunya vaccine, live)
    +
    etuvetidigene autotemcel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + etuvetidigene autotemcel

    contraindicated; vaccinate at least 6wk before myeloablative conditioning or after hematologic recovery: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • everolimus
  • Ixchiq (chikungunya vaccine, live)
    +
    everolimus
    1 interaction

    Contraindicated

    chikungunya vaccine, live + everolimus

    contraindicated; vaccinate at least 4wk before or 3mo after everolimus use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • fingolimod
  • Ixchiq (chikungunya vaccine, live)
    +
    fingolimod
    1 interaction

    Contraindicated

    chikungunya vaccine, live + fingolimod

    contraindicated; vaccinate at least 4wk before or 3mo after fingolimod tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • floxuridine
  • Ixchiq (chikungunya vaccine, live)
    +
    floxuridine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + floxuridine

    contraindicated; vaccinate at least 4wk before or 3mo after floxuridine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • fludarabine
  • Ixchiq (chikungunya vaccine, live)
    +
    fludarabine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + fludarabine

    contraindicated; vaccinate at least 4wk before or 3mo after fludarabine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • fludrocortisone
  • Ixchiq (chikungunya vaccine, live)
    +
    fludrocortisone
    1 interaction

    Contraindicated

    chikungunya vaccine, live + fludrocortisone

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • fluorouracil
  • Ixchiq (chikungunya vaccine, live)
    +
    fluorouracil
    1 interaction

    Contraindicated

    chikungunya vaccine, live + fluorouracil

    contraindicated; vaccinate at least 4wk before or 3mo after fluorouracil use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • fruquintinib
  • Ixchiq (chikungunya vaccine, live)
    +
    fruquintinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + fruquintinib

    contraindicated; vaccinate at least 4wk before or 3mo after fruquintinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • futibatinib
  • Ixchiq (chikungunya vaccine, live)
    +
    futibatinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + futibatinib

    contraindicated; vaccinate at least 4wk before or 3mo after futibatinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • gemcitabine
  • Ixchiq (chikungunya vaccine, live)
    +
    gemcitabine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + gemcitabine

    contraindicated; vaccinate at least 4wk before or 3mo after gemcitabine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • gemtuzumab ozogamicin
  • Ixchiq (chikungunya vaccine, live)
    +
    gemtuzumab ozogamicin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + gemtuzumab ozogamicin

    contraindicated; vaccinate at least 4wk before or 3mo after gemtuzumab ozogamicin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • glofitamab
  • Ixchiq (chikungunya vaccine, live)
    +
    glofitamab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + glofitamab

    contraindicated; vaccinate at least 4wk before or 6mo after glofitamab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • golimumab
  • Ixchiq (chikungunya vaccine, live)
    +
    golimumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + golimumab

    contraindicated; vaccinate at least 4wk before or 3mo after golimumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • guselkumab
  • Ixchiq (chikungunya vaccine, live)
    +
    guselkumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + guselkumab

    contraindicated; vaccinate at least 4wk before or 3mo after guselkumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • hydrocortisone
  • Ixchiq (chikungunya vaccine, live)
    +
    hydrocortisone
    1 interaction

    Contraindicated

    chikungunya vaccine, live + hydrocortisone

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroid use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • hydroxyurea
  • Ixchiq (chikungunya vaccine, live)
    +
    hydroxyurea
    1 interaction

    Contraindicated

    chikungunya vaccine, live + hydroxyurea

    contraindicated; vaccinate at least 4wk before or 3mo after hydroxyurea tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • iberdomide
  • Ixchiq (chikungunya vaccine, live)
    +
    iberdomide
    1 interaction

    Contraindicated

    chikungunya vaccine, live + iberdomide

    contraindicated; vaccinate at least 4wk before or 3mo after iberdomide use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ibritumomab tiuxetan
  • Ixchiq (chikungunya vaccine, live)
    +
    ibritumomab tiuxetan
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ibritumomab tiuxetan

    contraindicated; vaccinate at least 4wk before or 12mo after ibritumomab tiuxetan tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ibrutinib
  • Ixchiq (chikungunya vaccine, live)
    +
    ibrutinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ibrutinib

    contraindicated; vaccinate at least 4wk before or 3mo after ibrutinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • icotrokinra
  • Ixchiq (chikungunya vaccine, live)
    +
    icotrokinra
    1 interaction

    Contraindicated

    chikungunya vaccine, live + icotrokinra

    contraindicated; vaccinate at least 4wk before or 3mo after icotrokinra use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • idarubicin
  • Ixchiq (chikungunya vaccine, live)
    +
    idarubicin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + idarubicin

    contraindicated; vaccinate at least 4wk before or 3mo after idarubicin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • idecabtagene vicleucel
  • Ixchiq (chikungunya vaccine, live)
    +
    idecabtagene vicleucel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + idecabtagene vicleucel

    contraindicated; vaccinate at least 6wk before lymphodepleting chemotherapy or after immune recovery: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • idelalisib
  • Ixchiq (chikungunya vaccine, live)
    +
    idelalisib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + idelalisib

    contraindicated; vaccinate at least 4wk before or 3mo after idelalisib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ifosfamide
  • Ixchiq (chikungunya vaccine, live)
    +
    ifosfamide
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ifosfamide

    contraindicated; vaccinate at least 4wk before or 3mo after ifosfamide tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • imatinib
  • Ixchiq (chikungunya vaccine, live)
    +
    imatinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + imatinib

    contraindicated; vaccinate at least 4wk before or 3mo after imatinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • inebilizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    inebilizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + inebilizumab

    contraindicated; vaccinate at least 4wk before or 6mo after inebilizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • infliximab
  • Ixchiq (chikungunya vaccine, live)
    +
    infliximab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + infliximab

    contraindicated; vaccinate at least 4wk before or 3mo after infliximab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • inotuzumab ozogamicin
  • Ixchiq (chikungunya vaccine, live)
    +
    inotuzumab ozogamicin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + inotuzumab ozogamicin

    contraindicated; vaccinate at least 4wk before or 6mo after inotuzumab ozogamicin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ipilimumab
  • Ixchiq (chikungunya vaccine, live)
    +
    ipilimumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ipilimumab

    contraindicated; vaccinate at least 4wk before or 3mo after ipilimumab: combo may result in inadequate vaccine response, increase risk of disseminated infection (immunosuppressive effects)

  • irinotecan
  • Ixchiq (chikungunya vaccine, live)
    +
    irinotecan
    1 interaction

    Contraindicated

    chikungunya vaccine, live + irinotecan

    contraindicated; vaccinate at least 4wk before or 3mo after irinotecan tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • isatuximab
  • Ixchiq (chikungunya vaccine, live)
    +
    isatuximab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + isatuximab

    contraindicated; vaccinate at least 4wk before or 6mo after isatuximab use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ixabepilone
  • Ixchiq (chikungunya vaccine, live)
    +
    ixabepilone
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ixabepilone

    contraindicated; vaccinate at least 4wk before or 3mo after ixabepilone use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ixekizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    ixekizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ixekizumab

    contraindicated; vaccinate at least 4wk before or 3mo after ixekizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • lazertinib
  • Ixchiq (chikungunya vaccine, live)
    +
    lazertinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + lazertinib

    contraindicated; vaccinate at least 4wk before or 3mo after lazertinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • lebrikizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    lebrikizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + lebrikizumab

    contraindicated; vaccinate at least 4wk before or 3mo after lebrikizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • leflunomide
  • Ixchiq (chikungunya vaccine, live)
    +
    leflunomide
    1 interaction

    Contraindicated

    chikungunya vaccine, live + leflunomide

    contraindicated; vaccinate at least 4wk before or 6mo after leflunomide tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • lenalidomide
  • Ixchiq (chikungunya vaccine, live)
    +
    lenalidomide
    1 interaction

    Contraindicated

    chikungunya vaccine, live + lenalidomide

    contraindicated; vaccinate at least 4wk before or 3mo after lenalidomide tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • leniolisib
  • Ixchiq (chikungunya vaccine, live)
    +
    leniolisib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + leniolisib

    contraindicated; vaccinate at least 4wk before or 6mo after leniolisib use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunomodulatory effects)

  • lifileucel
  • Ixchiq (chikungunya vaccine, live)
    +
    lifileucel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + lifileucel

    contraindicated; vaccinate at least 4wk before or 3mo after lifileucel use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • linvoseltamab
  • Ixchiq (chikungunya vaccine, live)
    +
    linvoseltamab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + linvoseltamab

    contraindicated; vaccinate at least 4wk before or 6mo after linvoseltamab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • lisocabtagene maraleucel
  • Ixchiq (chikungunya vaccine, live)
    +
    lisocabtagene maraleucel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + lisocabtagene maraleucel

    contraindicated; vaccinate at least 6wk before lymphodepleting chemotherapy or after immune recovery: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • lomustine
  • Ixchiq (chikungunya vaccine, live)
    +
    lomustine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + lomustine

    contraindicated; vaccinate at least 4wk before or 3mo after lomustine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • loncastuximab tesirine
  • Ixchiq (chikungunya vaccine, live)
    +
    loncastuximab tesirine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + loncastuximab tesirine

    contraindicated; vaccinate at least 4wk before or 6mo after loncastuximab tesirine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • lymphocyte immune globulin, anti-thymocyte globulin
  • Ixchiq (chikungunya vaccine, live)
    +
    lymphocyte immune globulin, anti-thymocyte globulin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + lymphocyte immune globulin, anti-thymocyte globulin

    contraindicated; vaccinate at least 4wk before or 6mo after immunoglobulin use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • marnetegragene autotemcel
  • Ixchiq (chikungunya vaccine, live)
    +
    marnetegragene autotemcel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + marnetegragene autotemcel

    contraindicated; vaccinate at least 6wk before myeloablative conditioning or after hematologic recovery: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • melphalan
  • Ixchiq (chikungunya vaccine, live)
    +
    melphalan
    1 interaction

    Contraindicated

    chikungunya vaccine, live + melphalan

    contraindicated; vaccinate at least 4wk before or 3mo after melphalan tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • mercaptopurine
  • Ixchiq (chikungunya vaccine, live)
    +
    mercaptopurine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + mercaptopurine

    contraindicated; vaccinate at least 4wk before or 3mo after mercaptopurine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • methylprednisolone
  • Ixchiq (chikungunya vaccine, live)
    +
    methylprednisolone
    1 interaction

    Contraindicated

    chikungunya vaccine, live + methylprednisolone

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • mirikizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    mirikizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + mirikizumab

    contraindicated; vaccinate at least 4wk before or 3mo after mirikizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • mitoxantrone
  • Ixchiq (chikungunya vaccine, live)
    +
    mitoxantrone
    1 interaction

    Contraindicated

    chikungunya vaccine, live + mitoxantrone

    contraindicated; vaccinate at least 4wk before or 3mo after mitoxantrone tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • mogamulizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    mogamulizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + mogamulizumab

    contraindicated; vaccinate at least 4wk before or 3mo after mogamulizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • momelotinib
  • Ixchiq (chikungunya vaccine, live)
    +
    momelotinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + momelotinib

    contraindicated; vaccinate at least 4wk before or 3mo after momelotinib use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • monomethyl fumarate
  • Ixchiq (chikungunya vaccine, live)
    +
    monomethyl fumarate
    1 interaction

    Contraindicated

    chikungunya vaccine, live + monomethyl fumarate

    contraindicated; vaccinate at least 4wk before or 3mo after monomethyl fumarate tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • mosunetuzumab
  • Ixchiq (chikungunya vaccine, live)
    +
    mosunetuzumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + mosunetuzumab

    contraindicated; vaccinate at least 4wk before or 6mo after mosunetuzumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • mycophenolate mofetil
  • Ixchiq (chikungunya vaccine, live)
    +
    mycophenolate mofetil
    1 interaction

    Contraindicated

    chikungunya vaccine, live + mycophenolate mofetil

    contraindicated; vaccinate at least 4wk before or 3mo after mycophenolate mofetil tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • mycophenolic acid
  • Ixchiq (chikungunya vaccine, live)
    +
    mycophenolic acid
    1 interaction

    Contraindicated

    chikungunya vaccine, live + mycophenolic acid

    contraindicated; vaccinate at least 4wk before or 3mo after mycophenolic acid tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • natalizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    natalizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + natalizumab

    contraindicated; vaccinate at least 4wk before or 3mo after natalizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • nelarabine
  • Ixchiq (chikungunya vaccine, live)
    +
    nelarabine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + nelarabine

    contraindicated; vaccinate at least 4wk before or 3mo after nelarabine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • nemolizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    nemolizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + nemolizumab

    contraindicated; vaccinate at least 4wk before or 3mo after nemolizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • nilotinib
  • Ixchiq (chikungunya vaccine, live)
    +
    nilotinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + nilotinib

    contraindicated; vaccinate at least 4wk before or 3mo after nilotinib use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • nipocalimab
  • Ixchiq (chikungunya vaccine, live)
    +
    nipocalimab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + nipocalimab

    contraindicated; vaccinate at least 4wk before or 3mo after nipocalimab use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • nivolumab
  • Ixchiq (chikungunya vaccine, live)
    +
    nivolumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + nivolumab

    contraindicated; vaccinate at least 4wk before or 3mo after nivolumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • obecabtagene autoleucel
  • Ixchiq (chikungunya vaccine, live)
    +
    obecabtagene autoleucel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + obecabtagene autoleucel

    contraindicated; vaccinate at least 6wk before lymphodepleting chemotherapy or after immune recovery: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • obinutuzumab
  • Ixchiq (chikungunya vaccine, live)
    +
    obinutuzumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + obinutuzumab

    contraindicated; vaccinate at least 4wk before or 6mo after obinutuzumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ocrelizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    ocrelizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ocrelizumab

    contraindicated; vaccinate at least 4wk before or 6mo after ocrelizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ofatumumab
  • Ixchiq (chikungunya vaccine, live)
    +
    ofatumumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ofatumumab

    contraindicated; vaccinate at least 4wk before or 6mo after ofatumumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • oxaliplatin
  • Ixchiq (chikungunya vaccine, live)
    +
    oxaliplatin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + oxaliplatin

    contraindicated; vaccinate at least 4wk before or 3mo after oxaliplatin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ozanimod
  • Ixchiq (chikungunya vaccine, live)
    +
    ozanimod
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ozanimod

    contraindicated; vaccinate at least 1mo before or 3mo after ozanimod tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • paclitaxel
  • Ixchiq (chikungunya vaccine, live)
    +
    paclitaxel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + paclitaxel

    contraindicated; vaccinate at least 4wk before or 3mo after paclitaxel tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • pacritinib
  • Ixchiq (chikungunya vaccine, live)
    +
    pacritinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + pacritinib

    contraindicated; vaccinate at least 4wk before or 3mo after pacritinib use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • palbociclib
  • Ixchiq (chikungunya vaccine, live)
    +
    palbociclib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + palbociclib

    contraindicated; vaccinate at least 4wk before or 3mo after palbociclib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • pariglasgene brecaparvovec
  • Ixchiq (chikungunya vaccine, live)
    +
    pariglasgene brecaparvovec
    1 interaction

    Contraindicated

    chikungunya vaccine, live + pariglasgene brecaparvovec

    contraindicated; vaccinate at least 4wk before or 3mo after pariglasgene brecaparvovec use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • peginterferon alfa 2a
  • Ixchiq (chikungunya vaccine, live)
    +
    peginterferon alfa 2a
    1 interaction

    Contraindicated

    chikungunya vaccine, live + peginterferon alfa 2a

    contraindicated; vaccinate at least 4wk before or 3-6mo after peginterferon alfa 2a tx or immunocompetence restored: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • pembrolizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    pembrolizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + pembrolizumab

    contraindicated; vaccinate at least 4wk before or 3mo after pembrolizumab tx or immunocompetence restored: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • pemetrexed
  • Ixchiq (chikungunya vaccine, live)
    +
    pemetrexed
    1 interaction

    Contraindicated

    chikungunya vaccine, live + pemetrexed

    contraindicated; vaccinate at least 4wk before or 3mo after pemetrexed: combo may result in inadequate vaccine response, increase risk of disseminated infection (immunosuppressive effects)

  • penpulimab
  • Ixchiq (chikungunya vaccine, live)
    +
    penpulimab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + penpulimab

    contraindicated; vaccinate at least 4wk before or 3-6mo after penpulimab use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • pentostatin
  • Ixchiq (chikungunya vaccine, live)
    +
    pentostatin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + pentostatin

    contraindicated; vaccinate at least 4wk before or 3mo after pentostatin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • pertuzumab
  • Ixchiq (chikungunya vaccine, live)
    +
    pertuzumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + pertuzumab

    contraindicated; vaccinate at least 4wk before or 3mo after pertuzumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • pirtobrutinib
  • Ixchiq (chikungunya vaccine, live)
    +
    pirtobrutinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + pirtobrutinib

    contraindicated; vaccinate at least 4wk before or 3mo after pirtobrutinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • polatuzumab vedotin
  • Ixchiq (chikungunya vaccine, live)
    +
    polatuzumab vedotin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + polatuzumab vedotin

    contraindicated; vaccinate at least 4wk before or 6mo after polatuzumab vedotin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • pomalidomide
  • Ixchiq (chikungunya vaccine, live)
    +
    pomalidomide
    1 interaction

    Contraindicated

    chikungunya vaccine, live + pomalidomide

    contraindicated; vaccinate at least 4wk before or 3mo after pomalidomide tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ponatinib
  • Ixchiq (chikungunya vaccine, live)
    +
    ponatinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ponatinib

    contraindicated; vaccinate at least 4wk before or 3mo after ponatinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ponesimod
  • Ixchiq (chikungunya vaccine, live)
    +
    ponesimod
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ponesimod

    contraindicated; vaccinate at least 1mo before or 3mo after ponesimod tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • prednisolone
  • Ixchiq (chikungunya vaccine, live)
    +
    prednisolone
    1 interaction

    Contraindicated

    chikungunya vaccine, live + prednisolone

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • prednisone
  • Ixchiq (chikungunya vaccine, live)
    +
    prednisone
    1 interaction

    Contraindicated

    chikungunya vaccine, live + prednisone

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • procarbazine
  • Ixchiq (chikungunya vaccine, live)
    +
    procarbazine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + procarbazine

    contraindicated; vaccinate at least 4wk before or 3mo after procarbazine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • quizartinib
  • Ixchiq (chikungunya vaccine, live)
    +
    quizartinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + quizartinib

    contraindicated; vaccinate at least 4wk before or 3mo after quizartinib use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • regorafenib
  • Ixchiq (chikungunya vaccine, live)
    +
    regorafenib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + regorafenib

    contraindicated; vaccinate at least 4wk before or 3mo after regorafenib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • relacorilant
  • Ixchiq (chikungunya vaccine, live)
    +
    relacorilant
    1 interaction

    Contraindicated

    chikungunya vaccine, live + relacorilant

    contraindicated; vaccinate at least 4wk before or 3mo after relacorilant use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • relatlimab
  • Ixchiq (chikungunya vaccine, live)
    +
    relatlimab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + relatlimab

    contraindicated; vaccinate at least 4wk before or 3mo after relatlimab use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • retifanlimab
  • Ixchiq (chikungunya vaccine, live)
    +
    retifanlimab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + retifanlimab

    contraindicated; vaccinate at least 4wk before or 3-6mo after retifanlimab tx or immunocompetence restored: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • revumenib
  • Ixchiq (chikungunya vaccine, live)
    +
    revumenib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + revumenib

    contraindicated; vaccinate at least 4wk before or 3mo after revumenib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • rilonacept
  • Ixchiq (chikungunya vaccine, live)
    +
    rilonacept
    1 interaction

    Contraindicated

    chikungunya vaccine, live + rilonacept

    contraindicated; vaccinate at least 4wk before or 3mo after rilonacept tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • rilzabrutinib
  • Ixchiq (chikungunya vaccine, live)
    +
    rilzabrutinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + rilzabrutinib

    contraindicated; vaccinate at least 4wk before or 6mo after rilzabrutinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • risankizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    risankizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + risankizumab

    contraindicated; vaccinate at least 4wk before or 3mo after risankizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ritlecitinib
  • Ixchiq (chikungunya vaccine, live)
    +
    ritlecitinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ritlecitinib

    contraindicated; vaccinate at least 4wk before or 3mo after ritlecitinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • rituximab
  • Ixchiq (chikungunya vaccine, live)
    +
    rituximab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + rituximab

    contraindicated; vaccinate at least 4wk before or 6mo after rituximab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • romidepsin
  • Ixchiq (chikungunya vaccine, live)
    +
    romidepsin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + romidepsin

    contraindicated; vaccinate at least 4wk before or 3mo after romidepsin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ropeginterferon alfa-2b
  • Ixchiq (chikungunya vaccine, live)
    +
    ropeginterferon alfa-2b
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ropeginterferon alfa-2b

    contraindicated; vaccinate at least 4wk before or 3mo after ropeginterferon alfa-2b tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • rozanolixizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    rozanolixizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + rozanolixizumab

    contraindicated; vaccinate at least 4wk before or 3mo after rozanolixizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • rucaparib
  • Ixchiq (chikungunya vaccine, live)
    +
    rucaparib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + rucaparib

    contraindicated; vaccinate at least 4wk before or 3mo after rucaparib: combo may result in inadequate vaccine response, increase risk of disseminated infection (immunosuppressive effects)

  • ruxolitinib
  • Ixchiq (chikungunya vaccine, live)
    +
    ruxolitinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ruxolitinib

    contraindicated; vaccinate at least 4wk before or 3mo after ruxolitinib use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • sarilumab
  • Ixchiq (chikungunya vaccine, live)
    +
    sarilumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + sarilumab

    contraindicated; vaccinate at least 4wk before or 3mo after sarilumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • satralizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    satralizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + satralizumab

    contraindicated; vaccinate at least 4wk before or 3mo after satralizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • secukinumab
  • Ixchiq (chikungunya vaccine, live)
    +
    secukinumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + secukinumab

    contraindicated; vaccinate at least 4wk before or 3mo after secukinumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • selinexor
  • Ixchiq (chikungunya vaccine, live)
    +
    selinexor
    1 interaction

    Contraindicated

    chikungunya vaccine, live + selinexor

    contraindicated; vaccinate at least 4wk before or 3mo after selinexor tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • selumetinib
  • Ixchiq (chikungunya vaccine, live)
    +
    selumetinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + selumetinib

    contraindicated; vaccinate at least 4wk before or 3mo after selumetinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • sevabertinib
  • Ixchiq (chikungunya vaccine, live)
    +
    sevabertinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + sevabertinib

    contraindicated; vaccinate at least 4wk before or 3mo after sevabertinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • sibeprenlimab
  • Ixchiq (chikungunya vaccine, live)
    +
    sibeprenlimab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + sibeprenlimab

    contraindicated; vaccinate at least 4wk before or 6mo after sibeprenlimab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • siltuximab
  • Ixchiq (chikungunya vaccine, live)
    +
    siltuximab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + siltuximab

    contraindicated; vaccinate at least 4wk before or 3mo after siltuximab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • siponimod
  • Ixchiq (chikungunya vaccine, live)
    +
    siponimod
    1 interaction

    Contraindicated

    chikungunya vaccine, live + siponimod

    contraindicated; vaccinate at least 4wk before or 3mo after siponimod tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • sirolimus
  • Ixchiq (chikungunya vaccine, live)
    +
    sirolimus
    1 interaction

    Contraindicated

    chikungunya vaccine, live + sirolimus

    contraindicated; vaccinate at least 4wk before or 3mo after sirolimus tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • sirolimus albumin-bound
  • Ixchiq (chikungunya vaccine, live)
    +
    sirolimus albumin-bound
    1 interaction

    Contraindicated

    chikungunya vaccine, live + sirolimus albumin-bound

    contraindicated; vaccinate at least 4wk before or 3mo after sirolimus albumin-bound use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • sirolimus topical
  • Ixchiq (chikungunya vaccine, live)
    +
    sirolimus topical
    1 interaction

    Contraindicated

    chikungunya vaccine, live + sirolimus topical

    contraindicated; vaccinate at least 4wk before or 3mo after sirolimus tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • sonrotoclax
  • Ixchiq (chikungunya vaccine, live)
    +
    sonrotoclax
    1 interaction

    Contraindicated

    chikungunya vaccine, live + sonrotoclax

    contraindicated; vaccinate at least 4wk before or 6mo after sonrotoclax use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • sorafenib
  • Ixchiq (chikungunya vaccine, live)
    +
    sorafenib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + sorafenib

    contraindicated; vaccinate at least 4wk before or 3mo after sorafenib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • spesolimab
  • Ixchiq (chikungunya vaccine, live)
    +
    spesolimab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + spesolimab

    contraindicated; vaccinate at least 4wk before or 16wk after spesolimab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • sunitinib
  • Ixchiq (chikungunya vaccine, live)
    +
    sunitinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + sunitinib

    contraindicated; vaccinate at least 4wk before or 3mo after sunitinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • tacrolimus
  • Ixchiq (chikungunya vaccine, live)
    +
    tacrolimus
    1 interaction

    Contraindicated

    chikungunya vaccine, live + tacrolimus

    contraindicated; vaccinate at least 4wk before or 3mo after tacrolimus tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • tafasitamab
  • Ixchiq (chikungunya vaccine, live)
    +
    tafasitamab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + tafasitamab

    contraindicated; vaccinate at least 4wk before or 6mo after tafasitamab use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • taletrectinib
  • Ixchiq (chikungunya vaccine, live)
    +
    taletrectinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + taletrectinib

    contraindicated; vaccinate at least 4wk before or 3mo after taletrectinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • talquetamab
  • Ixchiq (chikungunya vaccine, live)
    +
    talquetamab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + talquetamab

    contraindicated; vaccinate at least 4wk before or 6mo after talquetamab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • tarlatamab
  • Ixchiq (chikungunya vaccine, live)
    +
    tarlatamab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + tarlatamab

    contraindicated; vaccinate at least 4wk before or 3mo after tarlatamab use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • teclistamab
  • Ixchiq (chikungunya vaccine, live)
    +
    teclistamab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + teclistamab

    contraindicated; vaccinate at least 4wk before or 6mo after teclistamab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • temozolomide
  • Ixchiq (chikungunya vaccine, live)
    +
    temozolomide
    1 interaction

    Contraindicated

    chikungunya vaccine, live + temozolomide

    contraindicated; vaccinate at least 4wk before or 3mo after temozolomide tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • temsirolimus
  • Ixchiq (chikungunya vaccine, live)
    +
    temsirolimus
    1 interaction

    Contraindicated

    chikungunya vaccine, live + temsirolimus

    contraindicated; vaccinate at least 4wk before or 3mo after temsirolimus use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • teplizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    teplizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + teplizumab

    contraindicated; vaccinate at least 8wk before or 52wk after teplizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • teriflunomide
  • Ixchiq (chikungunya vaccine, live)
    +
    teriflunomide
    1 interaction

    Contraindicated

    chikungunya vaccine, live + teriflunomide

    contraindicated; vaccinate at least 4wk before or 6mo after teriflunomide tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • thalidomide
  • Ixchiq (chikungunya vaccine, live)
    +
    thalidomide
    1 interaction

    Contraindicated

    chikungunya vaccine, live + thalidomide

    contraindicated; vaccinate at least 4wk before or 3mo after thalidomide use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • thioguanine
  • Ixchiq (chikungunya vaccine, live)
    +
    thioguanine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + thioguanine

    contraindicated; vaccinate at least 4wk before or 3mo after thioguanine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • thiotepa
  • Ixchiq (chikungunya vaccine, live)
    +
    thiotepa
    1 interaction

    Contraindicated

    chikungunya vaccine, live + thiotepa

    contraindicated; vaccinate at least 4wk before or 3mo after thiotepa tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • tildrakizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    tildrakizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + tildrakizumab

    contraindicated; vaccinate at least 4wk before or 3mo after tildrakizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • tisagenlecleucel
  • Ixchiq (chikungunya vaccine, live)
    +
    tisagenlecleucel
    1 interaction

    Contraindicated

    chikungunya vaccine, live + tisagenlecleucel

    contraindicated; vaccinate at least 6wk before lymphodepleting chemotherapy or after immune recovery: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • tislelizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    tislelizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + tislelizumab

    contraindicated; vaccinate at least 4wk before or 3-6mo after tislelizumab use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • tocilizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    tocilizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + tocilizumab

    contraindicated; vaccinate at least 4wk before or 3mo after tocilizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • tofacitinib
  • Ixchiq (chikungunya vaccine, live)
    +
    tofacitinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + tofacitinib

    contraindicated; vaccinate at least 4wk before or 3mo after tofacitinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • topotecan
  • Ixchiq (chikungunya vaccine, live)
    +
    topotecan
    1 interaction

    Contraindicated

    chikungunya vaccine, live + topotecan

    contraindicated; vaccinate at least 4wk before or 3mo after topotecan tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • toripalimab
  • Ixchiq (chikungunya vaccine, live)
    +
    toripalimab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + toripalimab

    contraindicated; vaccinate at least 4wk before or 3mo after toripalimab use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • trabectedin
  • Ixchiq (chikungunya vaccine, live)
    +
    trabectedin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + trabectedin

    contraindicated; vaccinate at least 4wk before or 3mo after trabectedin: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • tralokinumab
  • Ixchiq (chikungunya vaccine, live)
    +
    tralokinumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + tralokinumab

    contraindicated; vaccinate at least 4wk before or 3mo after tralokinumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • trastuzumab
  • Ixchiq (chikungunya vaccine, live)
    +
    trastuzumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + trastuzumab

    contraindicated; vaccinate at least 4wk before or 3mo after trastuzumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • tremelimumab
  • Ixchiq (chikungunya vaccine, live)
    +
    tremelimumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + tremelimumab

    contraindicated; vaccinate at least 4wk before or 3mo after tremelimumab use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • triamcinolone
  • Ixchiq (chikungunya vaccine, live)
    +
    triamcinolone
    1 interaction

    Contraindicated

    chikungunya vaccine, live + triamcinolone

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ublituximab
  • Ixchiq (chikungunya vaccine, live)
    +
    ublituximab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ublituximab

    contraindicated; vaccinate at least 4wk before or 6mo after ublituximab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • upadacitinib
  • Ixchiq (chikungunya vaccine, live)
    +
    upadacitinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + upadacitinib

    contraindicated; vaccinate at least 4wk before or 3mo after upadacitinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ustekinumab
  • Ixchiq (chikungunya vaccine, live)
    +
    ustekinumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ustekinumab

    contraindicated; vaccinate at least 4wk before or 3mo after ustekinumab use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • vamorolone
  • Ixchiq (chikungunya vaccine, live)
    +
    vamorolone
    1 interaction

    Contraindicated

    chikungunya vaccine, live + vamorolone

    contraindicated; vaccinate at least 6wk before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • vedolizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    vedolizumab
    1 interaction

    Contraindicated

    chikungunya vaccine, live + vedolizumab

    contraindicated; vaccinate at least 4wk before or 3mo after vedolizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • venetoclax
  • Ixchiq (chikungunya vaccine, live)
    +
    venetoclax
    1 interaction

    Contraindicated

    chikungunya vaccine, live + venetoclax

    contraindicated; vaccinate at least 4wk before or 6mo after venetoclax tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • vinblastine
  • Ixchiq (chikungunya vaccine, live)
    +
    vinblastine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + vinblastine

    contraindicated; vaccinate at least 4wk before or 3mo after vinblastine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • vincristine
  • Ixchiq (chikungunya vaccine, live)
    +
    vincristine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + vincristine

    contraindicated; vaccinate at least 4wk before or 3mo after vincristine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • vinorelbine
  • Ixchiq (chikungunya vaccine, live)
    +
    vinorelbine
    1 interaction

    Contraindicated

    chikungunya vaccine, live + vinorelbine

    contraindicated; vaccinate at least 4wk before or 3mo after vinorelbine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • voclosporin
  • Ixchiq (chikungunya vaccine, live)
    +
    voclosporin
    1 interaction

    Contraindicated

    chikungunya vaccine, live + voclosporin

    contraindicated; vaccinate at least 4wk before or 3mo after voclosporin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • zanubrutinib
  • Ixchiq (chikungunya vaccine, live)
    +
    zanubrutinib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + zanubrutinib

    contraindicated; vaccinate at least 4wk before or 3mo after zanubrutinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ziftomenib
  • Ixchiq (chikungunya vaccine, live)
    +
    ziftomenib
    1 interaction

    Contraindicated

    chikungunya vaccine, live + ziftomenib

    contraindicated; vaccinate at least 4wk before or 3mo after ziftomenib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

Avoid/Use Alternative

  • ado-trastuzumab emtansine
  • Ixchiq (chikungunya vaccine, live)
    +
    ado-trastuzumab emtansine
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + ado-trastuzumab emtansine

    avoid combo; vaccinate at least 4wk before or 3-6mo after ado-trastuzumab emtansine tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • avutometinib
  • Ixchiq (chikungunya vaccine, live)
    +
    avutometinib
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + avutometinib

    avoid combo; vaccinate at least 4wk before or 3-6mo after avutometinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • belzutifan
  • Ixchiq (chikungunya vaccine, live)
    +
    belzutifan
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + belzutifan

    avoid combo; vaccinate at least 4wk before or 3-6mo after belzutifan tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • bevacizumab
  • Ixchiq (chikungunya vaccine, live)
    +
    bevacizumab
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + bevacizumab

    avoid combo; vaccinate at least 4wk before or 3-6mo after bevacizumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • capmatinib
  • Ixchiq (chikungunya vaccine, live)
    +
    capmatinib
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + capmatinib

    avoid combo; vaccinate at least 4wk before or 3-6mo after capmatinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • cetuximab
  • Ixchiq (chikungunya vaccine, live)
    +
    cetuximab
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + cetuximab

    avoid combo; vaccinate at least 4wk before or 3-6mo after cetuximab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • defactinib
  • Ixchiq (chikungunya vaccine, live)
    +
    defactinib
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + defactinib

    avoid combo; vaccinate at least 4wk before or 3-6mo after defactinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • dordaviprone
  • Ixchiq (chikungunya vaccine, live)
    +
    dordaviprone
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + dordaviprone

    avoid combo; vaccinate at least 4wk before or 3-6mo after dordaviprone: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • fam-trastuzumab deruxtecan
  • Ixchiq (chikungunya vaccine, live)
    +
    fam-trastuzumab deruxtecan
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + fam-trastuzumab deruxtecan

    avoid combo; vaccinate at least 4wk before or 3-6mo after fam-trastuzumab deruxtecan tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • interferon gamma 1b
  • Ixchiq (chikungunya vaccine, live)
    +
    interferon gamma 1b
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + interferon gamma 1b

    avoid combo: combo may result in amplified immune response (immunomodulatory effects)

  • lurbinectedin
  • Ixchiq (chikungunya vaccine, live)
    +
    lurbinectedin
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + lurbinectedin

    avoid combo; vaccinate at least 4wk before or 3-6mo after lurbinectedin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • margetuximab
  • Ixchiq (chikungunya vaccine, live)
    +
    margetuximab
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + margetuximab

    avoid combo; vaccinate at least 4wk before or 3-6mo after margetuximab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • methotrexate
  • Ixchiq (chikungunya vaccine, live)
    +
    methotrexate
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + methotrexate

    avoid combo; vaccinate at least 4wk before or 3-6mo after methotrexate tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • mitomycin
  • Ixchiq (chikungunya vaccine, live)
    +
    mitomycin
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + mitomycin

    avoid combo; vaccinate at least 4wk before or 3-6mo after mitomycin: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • olaparib
  • Ixchiq (chikungunya vaccine, live)
    +
    olaparib
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + olaparib

    avoid combo; vaccinate at least 4wk before or 3-6mo after olaparib: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • panitumumab
  • Ixchiq (chikungunya vaccine, live)
    +
    panitumumab
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + panitumumab

    avoid combo; vaccinate at least 4wk before or 3-6mo after panitumumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • remibrutinib
  • Ixchiq (chikungunya vaccine, live)
    +
    remibrutinib
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + remibrutinib

    avoid combo; vaccinate at least 4wk before or 3mo after remibrutinib: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • ripretinib
  • Ixchiq (chikungunya vaccine, live)
    +
    ripretinib
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + ripretinib

    avoid combo; vaccinate at least 4wk before or 3-6mo after ripretinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • sunvozertinib
  • Ixchiq (chikungunya vaccine, live)
    +
    sunvozertinib
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + sunvozertinib

    avoid combo; vaccinate at least 4wk before or 3-6mo after sunvozertinib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • telisotuzumab vedotin
  • Ixchiq (chikungunya vaccine, live)
    +
    telisotuzumab vedotin
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + telisotuzumab vedotin

    avoid combo; vaccinate at least 4wk before or 3-6mo after telisotuzumab vedotin tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • tezepelumab
  • Ixchiq (chikungunya vaccine, live)
    +
    tezepelumab
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + tezepelumab

    avoid combo; consider vaccinating at least 4wk before or 3mo after tezepelumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (possible immunosuppressive effects)

  • vandetanib
  • Ixchiq (chikungunya vaccine, live)
    +
    vandetanib
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + vandetanib

    avoid combo; vaccinate at least 4wk before or 3-6mo after vandetanib tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • zanidatamab
  • Ixchiq (chikungunya vaccine, live)
    +
    zanidatamab
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + zanidatamab

    avoid combo; vaccinate at least 4wk before or 3-6mo after zanidatamab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • zenocutuzumab
  • Ixchiq (chikungunya vaccine, live)
    +
    zenocutuzumab
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + zenocutuzumab

    avoid combo; vaccinate at least 4wk before or 3-6mo after zenocutuzumab tx: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • zongertinib
  • Ixchiq (chikungunya vaccine, live)
    +
    zongertinib
    1 interaction

    Avoid/Use Alternative

    chikungunya vaccine, live + zongertinib

    avoid combo; vaccinate at least 4wk before or 3-6mo after zongertinib: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

Monitor/Modify Tx

  • budesonide rectal
  • Ixchiq (chikungunya vaccine, live)
    +
    budesonide rectal
    1 interaction

    Monitor/Modify Tx

    chikungunya vaccine, live + budesonide rectal

    consider vaccinating at least 1mo before or 1mo after budesonide rectal use: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • dengue vaccine, live
  • Ixchiq (chikungunya vaccine, live)
    +
    dengue vaccine, live
    1 interaction

    Monitor/Modify Tx

    chikungunya vaccine, live + dengue vaccine, live

    admin. at same visit or at least 4wk apart: combo may decr. response to 2nd vaccine if not administered together or >4wk apart (mechanism unknown)

  • ebola vaccine, live
  • Ixchiq (chikungunya vaccine, live)
    +
    ebola vaccine, live
    1 interaction

    Monitor/Modify Tx

    chikungunya vaccine, live + ebola vaccine, live

    admin. at same visit or at least 4wk apart: combo may decr. response to 2nd vaccine if not administered together or >4wk apart (mechanism unknown)

  • glatiramer
  • Ixchiq (chikungunya vaccine, live)
    +
    glatiramer
    1 interaction

    Monitor/Modify Tx

    chikungunya vaccine, live + glatiramer

    consider vaccinating 4wk before or 3-6mo after glatiramer tx or immunocompetence restored: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • influenza nasal vaccine, live
  • Ixchiq (chikungunya vaccine, live)
    +
    influenza nasal vaccine, live
    1 interaction

    Monitor/Modify Tx

    chikungunya vaccine, live + influenza nasal vaccine, live

    admin. at same visit or at least 4wk apart: combo may decr. response to 2nd vaccine if not administered together or >4wk apart (mechanism unknown)

  • interferon beta 1a
  • Ixchiq (chikungunya vaccine, live)
    +
    interferon beta 1a
    1 interaction

    Monitor/Modify Tx

    chikungunya vaccine, live + interferon beta 1a

    consider vaccinating at least 4wk before or 3mo after interferon beta 1a tx or immunocompetence restored: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • interferon beta 1b
  • Ixchiq (chikungunya vaccine, live)
    +
    interferon beta 1b
    1 interaction

    Monitor/Modify Tx

    chikungunya vaccine, live + interferon beta 1b

    consider vaccinating at least 4wk before or 3mo after interferon beta 1b tx or immunocompetence restored: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • measles/mumps/rubella vaccine, live
  • Ixchiq (chikungunya vaccine, live)
    +
    measles/ mumps/ rubella vaccine, live
    1 interaction

    Monitor/Modify Tx

    chikungunya vaccine, live + measles/ mumps/ rubella vaccine, live

    admin. at same visit or at least 4wk apart: combo may decr. response to 2nd vaccine if not administered together or >4wk apart (mechanism unknown)

  • peginterferon beta 1a
  • Ixchiq (chikungunya vaccine, live)
    +
    peginterferon beta 1a
    1 interaction

    Monitor/Modify Tx

    chikungunya vaccine, live + peginterferon beta 1a

    consider vaccinating at least 4wk before or 3mo after peginterferon beta 1a tx or immunocompetence restored: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • smallpox vaccine, live
  • Ixchiq (chikungunya vaccine, live)
    +
    smallpox vaccine, live
    1 interaction

    Monitor/Modify Tx

    chikungunya vaccine, live + smallpox vaccine, live

    admin. at same visit or at least 4wk apart: combo may decr. response to 2nd vaccine if not administered together or >4wk apart (mechanism unknown)

  • smallpox/mpox vaccine, live
  • Ixchiq (chikungunya vaccine, live)
    +
    smallpox/ mpox vaccine, live
    1 interaction

    Monitor/Modify Tx

    chikungunya vaccine, live + smallpox/ mpox vaccine, live

    admin. at same visit or at least 4wk apart: combo may decr. response to 2nd vaccine if not administered together or >4wk apart (mechanism unknown)

  • tuberculin purified protein derivative
  • Ixchiq (chikungunya vaccine, live)
    +
    tuberculin purified protein derivative
    1 interaction

    Monitor/Modify Tx

    chikungunya vaccine, live + tuberculin purified protein derivative

    admin. at same visit or at least 4-6wk apart: combo may interfere with test results (antagonistic effects)

  • varicella vaccine, live
  • Ixchiq (chikungunya vaccine, live)
    +
    varicella vaccine, live
    1 interaction

    Monitor/Modify Tx

    chikungunya vaccine, live + varicella vaccine, live

    admin. at same visit or at least 4wk apart: combo may decr. response to 2nd vaccine if not administered together or >4wk apart (mechanism unknown)

  • yellow fever vaccine, live
  • Ixchiq (chikungunya vaccine, live)
    +
    yellow fever vaccine, live
    1 interaction

    Monitor/Modify Tx

    chikungunya vaccine, live + yellow fever vaccine, live

    admin. at same visit or at least 30 days apart: combo may decr. response to 2nd vaccine if not administered together or >30 days apart (mechanism unknown)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@2dfa7165
  • hypersensitivity reaction
  • chikungunya-like reaction, prolonged
  • chikungunya-like reaction, severe
  • encephalitis

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@2f0692c5
  • headache
  • fatigue
  • leukopenia
  • neutropenia
  • myalgia
  • lymphopenia
  • arthralgia
  • fever
  • nausea
  • injection site reaction
  • rash
  • chills
  • diarrhea
  • back pain
  • lymphadenopathy

Safety/Monitoring .

Monitoring Parameters
no routine tests recommended

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy; monitor neonate for chikungunya disease x7 days after birth if gestational parent received chikungunya vaccine <14 days before birth; inadequate human data available; no known risk of fetal harm based on animal data at recommended human dose; theoretical risk of chikungunya virus transmission based on human data in infected pregnant patients with viremia

Pregnancy Registry

enroll patients or encourage patients to enroll in Ixchiq Pregnancy Registry at 1-855-417-6214

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; no human data available to assess risk of infant harm or effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@4b0ab8e

Metabolism: for chikungunya vaccine: other; CYP450: unknown

Excretion: for chikungunya vaccine: other; Half-life: unknown

Subclass: Chikungunya Vaccines ; Travel Vaccines

Mechanism of Action
for chikungunya vaccine: exact mechanism of action unknown; induces antibody formation

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Valneva USA, Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@2aa9c8ac

DEA/FDA: Rx

Pricing

Estimated prices are sourced from ScriptSave and based on the calculated national average across national pharmacy brand(s).

VIAL:

  • 1000 TCID (1 VIAL, 1 ml): $290.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information